Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice

Journal of Thrombosis and Haemostasis ◽

10.1111/jth.12657 ◽

2014 ◽

Vol 12 (10) ◽

pp. 1706-1716 ◽

Author(s):

S. A. Siefert ◽

C. Chabasse ◽

S. Mukhopadhyay ◽

M. H. Hoofnagle ◽

D. K. Strickland ◽

...

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Venous Thrombus ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Deficient Mice ◽

Activator Inhibitor

Download Full-text

The role of Plasminogen Activator Inhibitor Type‐2 (PAI‐2) in modulating venous thrombus resolution

The FASEB Journal ◽

10.1096/fasebj.2019.33.1_supplement.495.6 ◽

2019 ◽

Vol 33 (S1) ◽

Author(s):

Tierra A Johnson ◽

Subhradip Mukhopadhyay ◽

Nadire Duru ◽

Marguerite S Buzza ◽

Toni M Antalis

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Venous Thrombus ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

High plasminogen activator inhibitor type 2 expression is a hallmark of scleroderma fibroblasts in vitro

Experimental Dermatology ◽

10.1111/j.0906-6705.2004.00222.x ◽

2004 ◽

Vol 13 (11) ◽

pp. 708-714 ◽

Author(s):

Daniela Kessler-Becker ◽

Sigrun Smola ◽

Thomas Krieg ◽

Beate Eckes

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Translocation of plasminogen activator inhibitor type 2 in vivo: High expression levels result in intracellular polymerisation

Fibrinolysis and Proteolysis ◽

10.1016/0268-9499(94)90363-8 ◽

1994 ◽

Vol 8 ◽

pp. 28

Author(s):

P. Mikus ◽

T. Ny

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

High Expression ◽

Expression Levels ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Plasminogen activator inhibitor type 2 partly protects against tumor necrosis factor (TNF)-mediated cytolysis

Fibrinolysis and Proteolysis ◽

10.1016/0268-9499(94)90624-6 ◽

1994 ◽

Vol 8 ◽

pp. 121

Author(s):

P. Mikus ◽

T. Ny

Keyword(s):

Tumor Necrosis Factor ◽

Plasminogen Activator ◽

Tumor Necrosis ◽

Plasminogen Activator Inhibitor ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor ◽

Necrosis Factor

Download Full-text

Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2

Gene ◽

10.1016/0378-1119(93)90094-j ◽

1993 ◽

Vol 134 (2) ◽

pp. 201-208 ◽

Author(s):

Toni M. Antalis ◽

David Godbolt ◽

Karen D. Donnan ◽

Brett W. Stringer

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Regulatory Proteins ◽

Dna Encoding ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

The localization of the relaxed form of plasminogen activator inhibitor type 2 in human gingival tissues

Histochemistry and Cell Biology ◽

10.1007/s00418-001-0341-7 ◽

2001 ◽

Vol 116 (5) ◽

pp. 447-452 ◽

Author(s):

Pia Lindberg ◽

Mark S. Baker ◽

Bertil Kinnby

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Different radiolabelling methods alter the pharmacokinetic and biodistribution properties of Plasminogen Activator Inhibitor Type 2 (PAI-2) forms

Nuclear Medicine and Biology ◽

10.1016/j.nucmedbio.2012.01.006 ◽

2012 ◽

Vol 39 (6) ◽

pp. 833-839 ◽

Author(s):

Marie Ranson ◽

Paula Berghofer ◽

Kara L. Vine ◽

Ivan Greguric ◽

Rachael Shepherd ◽

...

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity

Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ◽

10.1016/s0167-4781(00)00041-5 ◽

2000 ◽

Vol 1492 (1) ◽

pp. 15-22 ◽

Author(s):

Anthony E. Dear ◽

Robert L. Medcalf

Keyword(s):

Plasminogen Activator ◽

Proteolytic Activity ◽

Plasminogen Activator Inhibitor ◽

The Novel ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Tissue Factor and Plasminogen Activator Inhibitor Type 2 Expression in Human Stimulated Monocytes is Inhibited by Heparin

Seminars in Thrombosis and Hemostasis ◽

10.1055/s-2007-996081 ◽

1997 ◽

Vol 23 (02) ◽

pp. 135-141 ◽

Author(s):

Guglielmina Pepe ◽

Betti Giusti ◽

Monica Attanasio ◽

Anna Gori ◽

Paolo Comeglio ◽

...

Keyword(s):

Tissue Factor ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Is plasminogen activator inhibitor type 2 really a plasminogen activator inhibitor after all?

Journal of Thrombosis and Haemostasis ◽

10.1111/jth.12704 ◽

2014 ◽

Vol 12 (10) ◽

pp. 1703-1705 ◽

Author(s):

E. E. Gardiner ◽

R. L. Medcalf

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text